KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Regeneron Pharmaceuticals (REGN) Inventory Average (2016 - 2025)

Regeneron Pharmaceuticals (REGN) has 12 years of Inventory Average data on record, last reported at $3.2 billion in Q4 2025.

  • For Q4 2025, Inventory Average rose 5.73% year-over-year to $3.2 billion; the TTM value through Dec 2025 reached $3.2 billion, up 5.73%, while the annual FY2025 figure was $3.1 billion, 10.94% up from the prior year.
  • Inventory Average reached $3.2 billion in Q4 2025 per REGN's latest filing, roughly flat from $3.2 billion in the prior quarter.
  • Across five years, Inventory Average topped out at $3.2 billion in Q3 2025 and bottomed at $2.0 billion in Q3 2021.
  • Average Inventory Average over 5 years is $2.6 billion, with a median of $2.5 billion recorded in 2023.
  • Peak YoY movement for Inventory Average: soared 40.91% in 2021, then dropped 0.88% in 2022.
  • A 5-year view of Inventory Average shows it stood at $2.0 billion in 2021, then grew by 19.23% to $2.4 billion in 2022, then grew by 6.82% to $2.6 billion in 2023, then rose by 18.72% to $3.1 billion in 2024, then increased by 5.73% to $3.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory Average were $3.2 billion in Q4 2025, $3.2 billion in Q3 2025, and $3.2 billion in Q2 2025.